Dr. Contact Lens came in at No. 3251 on the 2026 Inc. 5000, Inc.’s annual ranking of the fastest-growing private companies in America. It is the fourth year in a row the company has made the list.
We would rather spend this post on the part that matters more than the placement.
Inc. ranks companies on one thing: revenue growth over three years. Not headcount, not funding raised, not how well a company tells its own story.
Dr. Contact Lens revenue grows in exactly one way. A practice keeps a contact lens order that used to leave the building.
Which makes the ranking close to a direct readout of something worth caring about even if Inc. did not exist. Over three years, independent optometry practices pulled a meaningful amount of contact lens revenue back from online retailers, one reorder at a time. Every point of our growth began as a prescription that somebody used to walk out the door with.
That was the practice’s decision, made in the exam room and at the front desk, usually against the path of least resistance. The software was the easy part.
Plenty of companies land on the Inc. 5000 once. A single strong year, often after a small starting base, is enough to clear the bar.
Staying on it means clearing that bar again in a new three-year window, then again, then again. Four consecutive appearances means four separate measurement periods where the growth held up.
For us the mechanism behind that has been unglamorous and pretty consistent. A practice adopts the platform. Reorder rates climb because the friction that used to send patients elsewhere is gone. Patients stay with the practice that examined them. The next year that practice renews, and the loop runs again.
There is no clever growth story underneath it. There is a workflow problem that costs independent practices real money, and a lot of practices deciding to fix it.
Alongside the ranking, we spent part of last month asking practices what actually runs their front office.
Phones and scheduling came back first, ahead of anything clinical. Knowing their own numbers came second, because the reporting sits in several places at once and rarely agrees with itself. Myopia management turned out to be close to universal.
Almost none of that is about contact lenses, which is the useful part. The practices pulling ahead are not the ones buying the most software. They are the ones getting what they already own to work together.
That is the job in front of all of us this year, and it is a bigger one than ordering. We would rather be useful on it than quiet about it, so we have been writing about both: what to automate in the front office, and how to start a myopia program without buying anything new.
Dr. Rhue has said since the beginning: “The growth is theirs before it is ours.” Four years of this ranking is the clearest version of that on paper.
To every practice that decided contact lens revenue was worth fighting for: thank you. We are not close to done.
Seeing what the reorder experience looks like from the patient’s side is usually what makes the gap obvious, and it takes about two minutes.